Los Angeles Lakers guard Austin Reaves is having a career season, averaging 29.3 points per game and ranking fifth in the league in scoring this season. But fantastic as Reaves is playing this season ...
Abstract: Capturing stationary aerial objects on unmanned surface vehicles (USVs) is challenging due to quasiperiodic and fast floating-base motions caused by wave-induced disturbances. It is hard to ...
A happy couple who first met seven years ago when they both awoke from comas got engaged inside the same hospital where they were treated as teenagers. Zach Zarembinski popped the question to Isabelle ...
Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...
Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...
In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains Miriam Freimer, MD, an author on 5 abstracts presented at the recent 15th ...
After the CVE’s program’s near-death experience in April, might the Europeans be looking for a more reliable long-term system? From this week, the global technology industry has a new database to ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease caused by problems in the body's complement system, which normally helps fight infections. It damages tiny filters in your kidneys called ...
SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results